Anna Fontana
Via Aldo Moro 2
Siena, 53100, Italy
Siena, 53100, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting Class I Histone Deacetylases Triggers Antitumor Responses in Colorectal Cancer In Vitro and In Vivo.
Journal: Journal of medicinal chemistry
Published: January 05, 2026
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors.
Journal: ACS chemical neuroscience
Published: August 12, 2025
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients.
Journal: ACS pharmacology & translational science
Published: July 26, 2024
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy.
Journal: Journal of medicinal chemistry
Published: July 04, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies.
Journal: ACS pharmacology & translational science
Published: April 09, 2024
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors.
Journal: International journal of molecular sciences
Published: July 30, 2022
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability.
Journal: European journal of medicinal chemistry
Published: February 21, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026